{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-004547","form_type":"8-K","ticker":"AMLX","cik":"0001658551","company_name":"Amylyx Pharmaceuticals, Inc.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.341512+00:00","generated_at":"2026-05-28T05:10:00.897415+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Amylyx prices 17.1M-share public offering at $3.50/sh for ~$56.9M net proceeds","bullets":["Offering of 17,142,857 common shares at $3.50 per share, with 30-day option for up to 2,571,428 additional shares.","Net proceeds expected to be ~$56.9 million ($65.5 million if over-allotment exercised in full).","Closing expected January 13, 2025; proceeds to fund commercialization prep, pipeline, working capital.","Underwriting agreement includes customary representations, warranties, and market standoff provisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-004547","json":"https://secwatch.observer/filing/0001193125-25-004547.json","markdown":"https://secwatch.observer/filing/0001193125-25-004547.md","text":"https://secwatch.observer/filing/0001193125-25-004547.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658551/000119312525004547/0001193125-25-004547-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658551/000119312525004547/d917502d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T05:10:00.897415+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}